Browsing Tag

PRNewswire

24387 posts
Wing Chun connects cultures globally through dance drama

Wing Chun connects cultures globally through dance drama

BEIJING, Dec. 17, 2025 /PRNewswire/ — A news report from China Daily:…
WWF-Singapore's #WeGotThis 2025 Strengthens Regional Capacity for Youth-Led Climate and Nature Advocacy Across the Asia-Pacific

WWF-Singapore's #WeGotThis 2025 Strengthens Regional Capacity for Youth-Led Climate and Nature Advocacy Across the Asia-Pacific

SINGAPORE, Dec. 17, 2025 /PRNewswire/ — The World Wide Fund for Nature…

ATFX Group Honoured with Two Major Awards at FinanceFeeds Awards 2025

HONG KONG, Dec. 17, 2025 /PRNewswire/ — ATFX Group is proud to announce…
Basware's Acquisition of Redmap Signals a New Era for AP in Australia

Basware's Acquisition of Redmap Signals a New Era for AP in Australia

Global leader in Invoice Lifecycle Management combines with Australia’s leading provider of…
A New Industrial Benchmark – Niutech Intelligent Pyrolysis Equipment Empowering a World- Renowned Group for Chemical Recycling Project of Waste Plastic

A New Industrial Benchmark – Niutech Intelligent Pyrolysis Equipment Empowering a World- Renowned Group for Chemical Recycling Project of Waste Plastic

JINAN, China, Dec. 17, 2025 /PRNewswire/ — A well-known international group conducted…
The Largest-Scale Globally: Realsee Open-Sources Indoor 3D Dataset Realsee3D

The Largest-Scale Globally: Realsee Open-Sources Indoor 3D Dataset Realsee3D

BEIJING, Dec. 17, 2025 /PRNewswire/ — Realsee announced the official opening of…
The Largest-Scale Globally: Realsee Open-Sources Indoor 3D Dataset Realsee3D

The Largest-Scale Globally: Realsee Open-Sources Indoor 3D Dataset Realsee3D

BEIJING, Dec. 17, 2025 /PRNewswire/ — Realsee announced the official opening of…

Everest Medicines Announces that Licensing Partner LIB Therapeutics has Received U.S. FDA Approval of LEROCHOL™ (lerodalcibep-liga) for Adults with Elevated LDL Cholesterol

SHANGHAI, Dec. 17, 2025 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or…